Skip to main content

Table 3 Correlation between fatal PH and pathological characteristics

From: Risk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapy

  

No. of patients (%)

P value†

Characteristics

Non-fatal PH

Fatal PH

 

Overall number

571

12 (2.1)

 

Age (y)

median (range)

65 (31-85)

 
 

≤ 70

437 (76.5)

12 (100)

0.078

 

> 70

134 (23.5)

0 (0)

 

Gender

   
 

Male

472 (82.7)

10 (83.3)

1.000

 

Female

99 (17.3)

2 (16.7)

 

ECOG PS

   
 

0

170 (29.8)

1 (8.3)

0.196

 

1, 2

401 (70.2)

11 (91.7)

 

Smoking history

   
 

Non smoker

51 (8.9)

0 (0)

0.613

 

Ever-smoker

520 (91.1)

12 (100)

 

Histology

    
 

Squamous cell carcinoma

198 (34.7)

10 (83.3)

< 0.001*

 

Nonsquamous NSCLC

373 (65.3)

2 (16.7)

 

TNM stage

   
 

II

30 (5.3)

0 (0)

1.000

 

III

541 (94.7)

12 (100)

 

Tumor laterality

   
 

Right

341 (59.7)

5 (41.7)

0.242

 

Left

230 (40.3)

7 (58.3)

 

Tumor location

   
 

Central

121 (21.2)

6 (50.0)

0.028*

 

Peripheral

450 (78.8)

6 (50.0)

 

Major cavitation

   
 

Absent

560 (98.1)

9 (75.0)

< 0.001*

 

Present

11 (1.9)

3 (25.0)

 

Baseline cough

   
 

Absent

313 (54.8)

4 (33.3)

0.155

 

Present

258 (45.2)

8 (66.7)

 

Baseline chest pain

   
 

Absent

475 (83.2)

9 (75.0)

0.438

 

Present

96 (16.8)

3 (25.0)

 

Baseline hemoptysis

   
 

Absent

458 (80.2)

10 (83.3)

1.000

 

Present

113 (19.8)

2 (16.7)

 
  1. * indicates significance, †Fisher's exact test, PH: pulmonary hemorrhage, ECOG PS: Eastern Cooperative Oncology Group Performance Status, NSCLC: non-small cell lung cancer, Major cavitation is defined as its cavitation/tumor diameter ratio ≥ 0.5